Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate
- PMID: 6174658
Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate
Abstract
We have studied families C and A in which superactivity of PRPP synthetase (E.C. 2.7.6.1) is associated with gout and uric acid overproduction in affected hemizygous males. PRPP synthetase catalyzes synthesis of PRPP, a regulatory substrate in purine synthesis de novo. Activities of the enzyme in erythrocyte and fibroblast extracts from the male index cases, T.C. and R.A., were nearly threefold greater than normal at each Pi concentration tested. PRPP synthetase superactivity was accompanied by increased intracellular PRPP concentration and generation in erythrocytes and fibroblasts from these patients, and enhanced rates of PRPP-dependent purine synthesis reactions, including purine synthesis de novo, were demonstrable in their fibroblasts. These findings suggested that increased intracellular synthesis dut to enzyme superactivity underlay purine nucleotide and uric acid overproduction in these patients. Similar studies in cells from the sister of T.C. and the mother of R.A. showed increased values that were, however, intermediate between normal values and those of the affected males, indicating that these women are heterozygous carriers of the traits for enzyme superactivity. The enzymatic basis for increased PRPP synthetase activity in both families was investigated. Immunochemical studies in dialyzed erythrocyte lysates and highly purified erythrocyte enzyme preparations provided evidence for increased enzyme activity per molecule of immunoreactive enzyme. In addition, purified T.C. and R.A. PRPP synthetases showed 3.1- and 2.8-fold greater enzyme specific activities, respectively, than comparably purified normal enzymes. Kinetic constants of purified T.C. and R.A. PRPP synthetases for substrates, activators, and inhibitors were indistinguishable from normal, and increased maximal reaction velocity alone appeared to account for enzyme superactivity. Despite an apparently similar kinetic mechanism for superactivity, the diminished electrophoretic mobility of T.C. PRPP synthetase and increased thermal lability of R.A. PRPP synthetase suggested distinct structural alterations leading to enzyme superactivity in families C and A.
Similar articles
-
Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.J Clin Invest. 1975 Nov;56(5):1093-9. doi: 10.1172/JCI108183. J Clin Invest. 1975. PMID: 171280 Free PMC article.
-
Human phosphoribosylpyrophosphate synthetase: radioimmunochemical quantitation in erythrocytes and fibroblasts.J Lab Clin Med. 1984 Jul;104(1):96-109. J Lab Clin Med. 1984. PMID: 6330252
-
Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.J Clin Invest. 1976 Feb;57(2):308-18. doi: 10.1172/JCI108282. J Clin Invest. 1976. PMID: 176178 Free PMC article.
-
[PRPP synthetase superactivity].Nihon Rinsho. 1996 Dec;54(12):3309-14. Nihon Rinsho. 1996. PMID: 8976111 Review. Japanese.
-
[Increased activity of PRPP synthetase].Nihon Rinsho. 2008 Apr;66(4):694-8. Nihon Rinsho. 2008. PMID: 18409517 Review. Japanese.
Cited by
-
Developmental genetics.Experientia. 1986 Oct 15;42(10):1117-28. doi: 10.1007/BF01941286. Experientia. 1986. PMID: 3021509 Review.
-
PRPS1 mutations: four distinct syndromes and potential treatment.Am J Hum Genet. 2010 Apr 9;86(4):506-18. doi: 10.1016/j.ajhg.2010.02.024. Am J Hum Genet. 2010. PMID: 20380929 Free PMC article. Review.
-
Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in females.Rheumatology (Oxford). 2018 Jul 1;57(7):1180-1185. doi: 10.1093/rheumatology/key041. Rheumatology (Oxford). 2018. PMID: 30423175 Free PMC article.
-
Clinical and biochemical aspects of uric acid overproduction.Pharm World Sci. 1994 Apr 15;16(2):40-54. doi: 10.1007/BF01880655. Pharm World Sci. 1994. PMID: 8032341 Review.
-
Selective expression of phosphoribosylpyrophosphate synthetase superactivity in human lymphoblast lines.J Clin Invest. 1985 Oct;76(4):1657-64. doi: 10.1172/JCI112151. J Clin Invest. 1985. PMID: 2414323 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous